<DOC>
	<DOCNO>NCT00996879</DOCNO>
	<brief_summary>The purpose study assess effect BMS-791325 pharmacokinetics CYP3A4 Probe Midazolam .</brief_summary>
	<brief_title>Study Assess Effect BMS-791325 Pharmacokinetics Midazolam Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Healthy male female subject age 18 49 year , BMI 1832 kg/mÂ² Women childbearing potential Women childbearing potential Women pregnant , breastfeeding , unwilling unable use acceptable method birth control . Gastrointestinal disease may impact absorption study drug History chronic respiratory disease ( asthma , COPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Human Volunteers</keyword>
</DOC>